GSK plc
Blenrep
multiple myeloma
Resolved
69days ago
Approval decision · Apr 29, 2026
What's at stake
A final FDA approval decision on Blenrep for multiple myeloma is expected Apr 29, 2026.
Primary source
· SEC 6-K
verified 12h ago
“New product approvals for: Blenrep (China for multiple myeloma);”